Repare Therapeutics Inc (RPTX)
Repare Therapeutics Market Cap: 132.01M for May 23, 2024
Market Cap Chart
Historical Market Cap Data
Date | Value |
---|---|
May 22, 2024 | 140.07M |
May 21, 2024 | 144.31M |
May 20, 2024 | 147.71M |
May 17, 2024 | 150.68M |
May 16, 2024 | 149.83M |
May 15, 2024 | 151.53M |
May 14, 2024 | 156.62M |
May 13, 2024 | 157.05M |
May 10, 2024 | 148.56M |
May 09, 2024 | 154.50M |
May 08, 2024 | 160.87M |
May 07, 2024 | 139.22M |
May 06, 2024 | 144.31M |
May 03, 2024 | 146.44M |
May 02, 2024 | 142.19M |
May 01, 2024 | 140.07M |
April 30, 2024 | 131.58M |
April 29, 2024 | 135.83M |
April 26, 2024 | 135.83M |
April 25, 2024 | 133.70M |
April 24, 2024 | 140.07M |
April 23, 2024 | 142.62M |
April 22, 2024 | 138.37M |
April 19, 2024 | 133.70M |
April 18, 2024 | 128.19M |
Date | Value |
---|---|
April 17, 2024 | 136.25M |
April 16, 2024 | 141.77M |
April 15, 2024 | 147.29M |
April 12, 2024 | 154.93M |
April 11, 2024 | 165.54M |
April 10, 2024 | 167.23M |
April 09, 2024 | 167.23M |
April 08, 2024 | 171.48M |
April 05, 2024 | 168.93M |
April 04, 2024 | 165.54M |
April 03, 2024 | 174.45M |
April 02, 2024 | 184.64M |
April 01, 2024 | 199.49M |
March 28, 2024 | 198.68M |
March 27, 2024 | 196.99M |
March 26, 2024 | 191.09M |
March 25, 2024 | 200.79M |
March 22, 2024 | 206.27M |
March 21, 2024 | 219.35M |
March 20, 2024 | 222.30M |
March 19, 2024 | 221.03M |
March 18, 2024 | 218.08M |
March 15, 2024 | 223.14M |
March 14, 2024 | 220.19M |
March 13, 2024 | 227.78M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
Acasti Pharma Inc | 25.00M |
Aurinia Pharmaceuticals Inc | 750.14M |
Edesa Biotech Inc | 13.86M |
Lexaria Bioscience Corp | 36.85M |
InMed Pharmaceuticals Inc | 2.706M |
Market Cap Related Metrics
PS Ratio | 1.354 |
PEG Ratio | -0.0689 |
Price to Book Value | 0.5691 |
Price | 3.11 |
Earnings Yield | -35.37% |
PEGY Ratio | -0.0689 |